Study of PPI-668, BI 207127 and Faldaprevir, With and Without Ribavirin, in the Treatment of Chronic Hepatitis C
Clinical trial NCT01859962 · COMPLETED
Trial details
- NCT number
- NCT01859962
- Sponsor
- Presidio Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-01
- Primary completion
- 2014-05-01
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.